MITO 16B: Bevacizumab Maintenance with Platinum Doublets in Platinum-Sensitive Recurrence Last updated on Jun 8, 2026 Previous GOG 213: Bevacizumab Plus Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer Next OCEANS: Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer
